Market Research Report
Excipients in Pharmaceuticals: Global Markets to 2022
|Published by||BCC Research||Product code||664132|
|Published||Content info||186 Pages
Delivery time: 1-2 business days
|Excipients in Pharmaceuticals: Global Markets to 2022|
|Published: April 10, 2018||Content info: 186 Pages||
The global market for pharmaceutical excipients will grow from nearly $6.8 billion in 2017 to $8.7 billion by 2022 with a compound annual growth rate (CAGR) of 4.9% for the period of 2017-2022.
Organic excipient market will grow from nearly $6.4 billion in 2017 to $8.1 billion by 2022 with a CAGR of 5.0%.
Inorganic excipient market will grow from nearly $324.6 million in 2017 to $391.3 million by 2022 with a CAGR of 3.8%.
This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry. A detailed analysis illustrating market dynamics, market structure analysis incorporating Porter's Five Force Framework analysis and supply chain and distribution is discussed in detail. Excluded from the scope of this report is the use of excipients in cosmetics, food and beverage, and chemical industries. Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market is also analyzed.
Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients and USP Water. Based on route of administration, the pharmaceutical excipient market is segmented by-oral, injectable/parenteral, topical and advanced delivery systems. By dosage forms, the pharmaceutical excipients market is segmented as solid dosage forms, liquid dosage forms, semi-solid dosage forms, and others (e.g., aerosol and powder). By end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators and others (e.g., academics and pharmacies). This report includes market size estimates for 2016 as the base year, 2017, and forecast estimates for 2022.
Geographically, this report analyzes the market by the following regions: North America, Europe, Asia-Pacific, Latin America and the Middle East. Key countries with a high concentration of pharma manufacturing companies and contract manufacturing organizations, including the U.S., Europe (Germany, U.K., Italy, France and Spain), China, India and Brazil are discussed. A detailed competitive analysis of key leading pharmaceutical excipient suppliers is provided, detailing business operations and segment focus.